Novartis to acquire Avidity Biosciences for about $12 billion – Reuters

Written by

admin

in

  1. Novartis to acquire Avidity Biosciences for about $12 billion  Reuters
  2. Novartis (NVS) Announces Acquisition of Avidity Biosciences  GuruFocus
  3. Novartis Agrees to Buy Avidity in $12 Billion Biotech Deal  Bloomberg.com
  4. Novartis to buy Avidity and its neuromuscular RNA pipeline for $12B  FirstWord Pharma
  5. Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG  PR Newswire

Continue Reading

More posts